Recall Atlas
Drugs & medicalClass II

AEQUITA PHARMACY recalls Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose…

Lack of Processing Controls.

Read the official notice →
Date
2025-08-13
Country
United States
Brand
AEQUITA PHARMACY
Product
Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose…
Classification
Class II
Units
MA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2025-08-13
  2. US
    Drugs & medicalClass II

    Cardinal Health Inc. recalls RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01

    CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

    FDA · DrugCardinal Health Inc.Nationwide Within the U.S.Official notice →
  3. US
    Drugs & medicalClass II

    Direct Rx recalls Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc.,…

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

    FDA · DrugDirect RxNationwideOfficial notice →
  4. US
    Drugs & medicalClass II

    Alembic Pharmaceuticals Limited recalls Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v…

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

    FDA · DrugAlembic Pharmaceuticals LimitedNationwide in the USA.Official notice →
  5. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 60mg, 1,000-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L.…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit

    FDA · DrugBreckenridge Pharmaceutical, Inc.U.S NationwideOfficial notice →
  6. 2025-08-06
  7. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, Dual Y-Site (Qty 25). Product Code: SET-0032-25.

    Potential for external cassette leaks

    FDA · DeviceFresenius Kabi USA, LLCUS Nationwide distribution in the states of CA, CO, DE, FL, GA, ID, IL, MA,…Official notice →
  8. US
    Drugs & medicalClass II

    3M Company recalls 3M Ranger Irrigation Fluid Warming Set, REF 24750

    Notice was issued to clarify flow rates related to the inlet fluid temperature.

    FDA · Device3M CompanyUS (nationwide) and Argentina, Australia, Austria, Belgium, Bosnia and…Official notice →
See all drugs & medical recalls →